STOCK TITAN
  1. Home
  2. Sec-filings
  3. ARTL
  4. [EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing

[EFFECT] ARTELO BIOSCIENCES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 25, 2026 5:00 P.M.
Form: S-1
CIK: 0001621221
Company Name: ARTELO BIOSCIENCES, INC.
File Number: 333-294506

Source: View Original Filing on SEC EDGAR

Artelo Biosciences Inc

NASDAQ:ARTL

View ARTL Stock Overview →

ARTL Rankings

#6933 Ranked by Market Cap
N/A Ranked by Dividends

ARTL Latest News

Mar 27, 2026
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Mar 25, 2026
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Mar 25, 2026
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
Mar 18, 2026
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
Mar 18, 2026
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients

ARTL Latest SEC Filings

Mar 27, 2026
[RW] ARTELO BIOSCIENCES, INC. SEC Filing
Mar 26, 2026
[8-K] ARTELO BIOSCIENCES, INC. Reports Material Event
Mar 24, 2026
[S-1] ARTELO BIOSCIENCES, INC. Files IPO Registration Statement
Mar 24, 2026
[S-1/A] ARTELO BIOSCIENCES, INC. Amends IPO Registration Statement
Mar 23, 2026
[S-1/A] ARTELO BIOSCIENCES, INC. Amends IPO Registration Statement

ARTL Stock Data

2.35M
716.48k
Biotechnology
Pharmaceutical Preparations
Link
United States
SOLANA BEACH